 |
|
Stroke Treatment
Promising but Still Struggling
Louis R. Caplan, MD
JAMA. 1998;279:1304-1306.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Just 2 scant decades ago, the stroke exhibit at the Museum of Science and Industry in Chicago, Ill, featured wheelchairs, braces, and various other devices that aided mobilization of patients with paralysis after strokes. While these aids help improve function for those with residual impairment, prevention and treatment were not addressed. Not surprisingly, stroke was then and remains today the single disease that older individuals most fear. No one wants to spend their crowning years dependent on others and with impaired mental and physical faculties. Even so, during the first three quarters of the 20th century, stroke was a disorder of little medical interest. Most physicians thought there was little that could be done to prevent stroke or treat patients with stroke. Few physicians were interested in stroke. Therapeutic nihilism prevailed.
The atmosphere has changed dramatically during the last decade of this century. Stroke, the third . . . [Full Text of this Article]
From the Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Mass.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
Low Molecular Weight Heparinoid, ORG 10172 (Danaparoid), and Outcome After Acute Ischemic Stroke: A Randomized Controlled Trial
The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment Investigators
JAMA. 1998;279(16):1265-1272.
ABSTRACT
| FULL TEXT
Patients With Nonvalvular Atrial Fibrillation at Low Risk of Stroke During Treatment With Aspirin: Stroke Prevention in Atrial Fibrillation III Study
The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators
JAMA. 1998;279(16):1273-1277.
ABSTRACT
| FULL TEXT
Variation in Carotid Endarterectomy Mortality in the Medicare Population: Trial Hospitals, Volume, and Patient Characteristics
David E. Wennberg, F. L. Lucas, John D. Birkmeyer, Carl E. Bredenberg, and Elliott S. Fisher
JAMA. 1998;279(16):1278-1281.
ABSTRACT
| FULL TEXT
Indications, Outcomes, and Provider Volumes for Carotid Endarterectomy
Randall D. Cebul, Richard J. Snow, Richard Pine, Norman R. Hertzer, and Donald G. Norris
JAMA. 1998;279(16):1282-1287.
ABSTRACT
| FULL TEXT
Further Evolution Toward Effective Therapy for Acute Ischemic Stroke
Marc Fisher and Julien Bogousslavsky
JAMA. 1998;279(16):1298-1303.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Treatment of Acute Stroke: Still Struggling
Caplan
JAMA 2004;292:1883-1885.
FULL TEXT
Medical school attended as a predictor of medical malpractice claims
Waters et al.
Qual Saf Health Care 2003;12:330-336.
ABSTRACT
| FULL TEXT
Utilization of Intravenous Tissue-Type Plasminogen Activator for Ischemic Stroke at Academic Medical Centers : The Influence of Ethnicity Editorial Comment : It Is Time to Implement Stroke Practice Improvement Programs and Prevent the Racial Disparity in Stroke Care
Johnston et al.
Stroke 2001;32:1061-1068.
ABSTRACT
| FULL TEXT
Stroke Treatment Economic Model (STEM) : Predicting Long-Term Costs From Functional Status
Caro and Huybrechts
Stroke 1999;30:2574-2579.
ABSTRACT
| FULL TEXT
Recent progress in drug treatment for acute stroke
DEVUYST and BOGOUSSLAVSKY
J. Neurol. Neurosurg. Psychiatry 1999;67:420-425.
FULL TEXT
Retinal Emboli and Stroke: The Beaver Dam Eye Study
Klein et al.
Arch Ophthalmol 1999;117:1063-1068.
ABSTRACT
| FULL TEXT
|
